Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05245201 · ClinicalTrials.gov registry record · NA
Clinical Decision Support for PrEP
A NA study of HIV Infections and Preexposure Prophylaxis (PrEP), sponsored by Harvard Pilgrim Health Care.
- Active
- Registry status
- NA
- Development phase
- 4
- Enrollment target
- 3
- Study locations
NCT05245201 is a NA study of HIV Infections and Preexposure Prophylaxis (PrEP) that is active but no longer recruiting, run by Harvard Pilgrim Health Care. The registered enrollment target is 4 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT05245201, a NA study of HIV Infections and Preexposure Prophylaxis (PrEP), is active but no longer recruiting, sponsored by Harvard Pilgrim Health Care.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
- 3
- Study locations
Study Summary
Scale-up of HIV preexposure prophylaxis (PrEP) is a key strategy of the federal initiative to end the HIV epidemic. However, healthcare providers lack tools to identify patients who are at increased risk for HIV infection and thus likely to benefit from PrEP. This pilot study will test the hypothesis that an electronic health record (EHR)-based clinical decision support system that incorporates an HIV risk prediction model can help providers identify patients at increased risk for HIV infection and improve PrEP prescribing in safety-net community health centers. The clinical decision support system will be implemented in the EHR at 2-3intervention clinics, while 2 control clinics will receive standard of care. The primary outcome is PrEP prescriptions. Other key metrics of PrEP-related care to be assessed include medication persistence, adherence to monitoring guidelines for PrEP, and rates of HIV/STI testing and diagnoses. The expected outcome is the foundation for a large-scale cluster randomized trial to test whether EHR-based clinical decision support tools for PrEP can improve PrEP prescribing and prevent new HIV infections in a national network of community health centers.
Conditions Studied
Interventions
- OTHER Standard of care
- OTHER Clinical decision support for PrEP
Study Locations (3)
North Carolina
- Roanoke Chowan Community Health Center - Ahoskie
- Kintegra Health - Gastonia
California
- Saban Community Clinic - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2022-07-11 |
| Est. Completion | 2027-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05245201
The ClinicalTrials.gov registry entry for NCT05245201 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (99% lower). The listed sponsor is Harvard Pilgrim Health Care, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Standard of care is the first listed.
NCT05245201 reports 3 study locations spanning 2 distinct geographic areas - top geographies include North Carolina, California.
Frequently Asked Questions
What is clinical trial NCT05245201 about?
NCT05245201 is a clinical study titled "Clinical Decision Support for PrEP". Scale-up of HIV preexposure prophylaxis (PrEP) is a key strategy of the federal initiative to end the HIV epidemic. However, healthcare providers lack tools to identify patients who are at increased risk for HIV infection and thus likely to benefit from PrEP. This pilot study will test the hypothesi...
What is the current status of trial NCT05245201?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 4 participants. The study started on 2022-07-11. Estimated completion is 2027-08.
What conditions does trial NCT05245201 study?
This clinical trial studies the following conditions: HIV Infections, Preexposure Prophylaxis (PrEP).
What interventions are being tested in trial NCT05245201?
The interventions under investigation include: Standard of care (OTHER), Clinical decision support for PrEP (OTHER).
Who is sponsoring clinical trial NCT05245201?
This trial is sponsored by Harvard Pilgrim Health Care, which has 28 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05245201 being conducted?
This trial has 3 study locations across California, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.